Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Community Pharmacy MMR Enhanced Service

NHS England (London Region) · compiled

Tender information last checkedLast checked 30 Sept 2026, 00:31.

Opportunity overview

NHS England (London Region) direct award C under PSR23 for Community Pharmacy MMR Enhanced Service

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

  • CPV85100000 — Health services

Lots

  • The notice relates to Community Pharmacy MMR Enhanced health care services. This notice is an intention to award a contract to the existing provider following direct award process C. The lifetime Value of the contract is activity based determined by the £10.06 single fee per administration. The contract term will be 1 year. The contract will start on 01/04/2025 and end 31/03/2026Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-050490
Status
complete
Procurement Method
limited
Main Procurement Category
services
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 01/05/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrrepresentation@nhs.net Award Decision makers: Dawn Hollis Head of ANNB Screening, Immunisations, CHIS, ICARS, Digital Transformation Decision made: 06/03/2025 5 key criteria selected: (1) Quality and Innovation: 20% (2) Value: 20% (3) Integration, collaboration and service sustainability: 20% (4) Improving access, reducing health inequalities and facilitating choice: 20% (5) Social value: 20% Providers assessed on a Pass/Fail basis against 3 basic selection criteria. All Scored and Pass/Fail criteria are met. No conflicts of interest declared.

Covered By

GPA

Amendments

Entry 1
Id
2
Description
Corrigendum Notice to Contract Award Notice F14. Confirmation of the Decision. This is a Provider Selection Regime (PSR) confirmation of Contract Award Notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using Direct Award Process C. An Intention to Award Notice for this requirement was published on 17 April 2025. The Service contract shall cover the period from 01 April 2025 to 31 March 2026.

Unstructured Changes

Entry 1

Where

Section
I

New Value

Text
No changes

Old Value

Text
N/A

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Id
85100000
Scheme
CPV
Description
Health services

Procedure reasons

Entry 1
Id
D_OUTSIDE_SCOPE
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Status
cancelled
Has Options
No
Description
The notice relates to Community Pharmacy MMR Enhanced health care services. This notice is an intention to award a contract to the existing provider following direct award process C. The lifetime Value of the contract is activity based determined by the £10.06 single fee per administration. The contract term will be 1 year. The contract will start on 01/04/2025 and end 31/03/2026

Award criteria

Criteria

Criterion 1
Name
The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard
Type
quality
Description
100
Criterion 2
Type
price
Description
0

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKI

Buyer, suppliers and contacts

Organisation 1
Id
GB-NHS-Y56
Name
NHS England (London Region)

Roles

buyer

Address

Region
UKI
Locality
London
Postal Code
SE1 8UG
Country Name
United Kingdom
Street Address
Wellington House, 133-135 Waterloo Road

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Id
Y56
Scheme
GB-NHS
Legal Name
NHS England (London Region)

Contact

Name
Thomas Crouch
Organisation 2
Id
GB-FTS-144480
Name
33 Community Pharmacies across London

Roles

supplier

Address

Region
UKI
Locality
London
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
33 Community Pharmacies across London
No Identifier Rationale
notOnAnyRegister
Organisation 3
Id
GB-FTS-7114
Name
NHS England

Roles

reviewBody

Address

Locality
London
Country Name
United Kingdom

Identifier

Legal Name
NHS England

Award information

Award 1
Id
015788-2025-1
Status
active

Suppliers

Supplier 1
Id
GB-FTS-144480
Name
33 Community Pharmacies across London

Related lots

1

Contracts and changes

Entry 1
Id
015788-2025-1
Status
active
Award ID
015788-2025-1
Date Signed
17 Apr 2025, 00:00

Value

Amount
1
Currency
GBP

Recorded locations

  • Buyer location · London · UKI · SE1 8UG · United Kingdom
  • Delivery location · UKI

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-050490-2025-05-09T10:18:08+01:00compiled ·